whytee, you mention responsiveness to l-dopa. during the cc it was mentioned that all the patients in the phase1 trial had been approved for DBS and 1 criteria for that is good l-dopa responsiveness. it was stated all patients in phase2 had been diagnosed at least 5 years ago, under 65 and were heading towards getting a DBS eventually which implies L-DOPA responsiveness, i'm sure they must have measured them ON and OFF in the UPDRS motor test to make sure the responded well to l-dopa. you take the test 10hrs after your last meds, then take your meds and re-test 90minutes later. i assume they tried to select patients that didn't have atypical parkinson's. if you go to a parkinson's support group you'll quickly see no 2 pd'ers are alike.
- Forums
- ASX - By Stock
- 1AI
- Ann: Results of LCT Parkinsons trial require further analysis
Ann: Results of LCT Parkinsons trial require further analysis, page-109
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $4.495K | 642.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 4953269 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 954858 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 4953269 | 0.007 |
9 | 2486749 | 0.006 |
5 | 2410009 | 0.005 |
4 | 4065000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 954858 | 11 |
0.009 | 2278303 | 12 |
0.010 | 2651050 | 4 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online